Testing effectiveness (Phase 2)Ended earlyNCT03148327
What this trial is testing
Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jonsson Comprehensive Cancer Center 18